Kazuharu Kamachi

7PUBLICATIONS
31CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Contaminant hydrology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 17, 2026
Dual MYC and GSPT1 Protein Degrader for MYC-Driven Hematologic Malignancies.

|Jan 08, 2024
Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cells.

Tatsuro Watanabe, Yuta Yamamoto, Yuki Kurahashi

|Oct 28, 2023
A Combination of Alectinib and DNA-Demethylating Agents Synergistically Inhibits Anaplastic-Lymphoma-Kinase-Positive Anaplastic Large-Cell Lymphoma Cell Proliferation.

Kazunori Kawasoe, Tatsuro Watanabe, Nao Yoshida-Sakai

|Mar 02, 2023
Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia.

Kazuharu Kamachi, Hiroshi Ureshino, Tatsuro Watanabe

|Nov 03, 2022
Higher neutrophil counts are associated with successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia.

Hiroshi Ureshino, Kazuharu Kamachi, Haruhiko Sano

|Oct 03, 2022
Eosinophilic cystitis mimicking hemorrhagic cystitis in relapsed follicular lymphoma.

Toshiaki Nagaie, Kazuharu Kamachi, Hiroaki Kitamura

Pageof 2

Frequent Collaborators

4 joint publications

Hiroshi Ureshino

2 joint publications

Shinya Kimura

2 joint publications

Tatsuro Watanabe

2 joint publications

Nao Yoshida-Sakai